Fundraising Fox
Signature Diagnostics
19 employees on LinkedIn · 1 known investors
Find your way into Signature Diagnostics
Sign up to see every warm intro you have to Signature Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Signature Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Signature Diagnostics develops noninvasive diagnostic and screening tools, including noninvasive prenatal screening (NIPS) and pharmacogenomic (PGx) testing, based on genomics research into women's reproductive and organ health. It operates SDxLabs, a CLIA-certified clinical lab offering these testing services.
Founders & leadership
DC
Dave ColaizziCo-founder & Chief Executive OfficerDave Colaizzi is Chief Executive Officer and co-founder of Signature Diagnostics, which develops noninvasive diagnostic and screening tools based on genomics research. He previously co-founded and led software company fivestar* as CEO, and held leadership roles in the acquisition and sale of genetic testing companies Genelex and YouScript.
DP
David PetersCo-founder & Chief Science OfficerDavid Peters is Co-founder and Chief Science Officer of Signature Diagnostics, which develops noninvasive diagnostic and screening tools including prenatal and pharmacogenomic testing. He has worked in higher education and consulting with expertise in precision medicine, genomics, and bioinformatics.
TC
Tianjiao ChuChief Analytical Officer
Investors · 1
Related companies · 4
NateraNatera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IDbyDNAScalable, high throughput DNA sequencing platforms.
Pink DxPinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
Companies working in the same space as Signature Diagnostics.
Frequently asked questions
- What does Signature Diagnostics do?
- Signature Diagnostics develops noninvasive diagnostic and screening tools, including noninvasive prenatal screening (NIPS) and pharmacogenomic (PGx) testing, based on genomics research into women's reproductive and organ health. It operates SDxLabs, a CLIA-certified clinical lab offering these testing services.
- Who founded Signature Diagnostics?
- Signature Diagnostics was founded by Dave Colaizzi, David Peters.
- Who are Signature Diagnostics's investors?
- Signature Diagnostics's investors include Life Sciences Greenhouse Investments.